Results 31 to 40 of about 16,494 (203)

Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication

open access: yesViruses, 2022
Viral replication and transmissibility are the principal causes of endemic and pandemic disease threats. There remains a need for broad-spectrum antiviral agents.
R. Tripp, David E Martin
semanticscholar   +1 more source

Drug repurposing for cardiovascular diseases: New targets and indications for probenecid

open access: yesBritish Journal of Pharmacology, 2022
The available pharmacological options in the management of cardiovascular diseases such as ischaemic heart disease and subsequent heart failure are effective in slowing the progression of this condition.
Zsófia Onódi   +4 more
semanticscholar   +1 more source

Addition of probenecid to oral β-lactam antibiotics: a systematic review and meta-analysis

open access: yesJournal of Antimicrobial Chemotherapy, 2022
Objectives To explore the literature comparing the pharmacokinetic and clinical outcomes from adding probenecid to oral β-lactams. Methods Medline and EMBASE were searched from inception to December 2021 for all English language studies comparing the ...
Richard C. Wilson   +7 more
semanticscholar   +1 more source

Effect of Probenecid on Endothelial Cell Growth Rate and Retinal Angiogenesis in an Oxygen-Induced Retinopathy Model

open access: yesFrontiers in Pharmacology, 2021
Objectives: Probenecid is an anion transport inhibitor, which, according to the connectivity map (CMap; a biological application database), interferes with hypoxia-induced gene expression changes in retinal vascular endothelial cells (ECs).
Jingbo Jiang   +10 more
doaj   +1 more source

Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro

open access: yesScientific Reports, 2021
Effective vaccines are slowing the COVID-19 pandemic, but SARS-CoV-2 will likely remain an issue in the future making it important to have therapeutics to treat patients. There are few options for treating patients with COVID-19.
J. Murray   +8 more
semanticscholar   +1 more source

Neuroprotective Effects of the Pannexin-1 Channel Inhibitor: Probenecid on Spinal Cord Injury in Rats

open access: yesFrontiers in Molecular Neuroscience, 2022
Proinflammatory immune cell subsets constitute the majority in the local microenvironment after spinal cord injury (SCI), leading to secondary pathological injury.
Qi Qi   +14 more
doaj   +1 more source

Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment

open access: yesTherapeutic Advances in Medical Oncology, 2022
Introduction: In breast cancer patients treated with the anti-estrogen tamoxifen, low concentrations of the active metabolite endoxifen are associated with more disease recurrence.
Stefan A. J. Buck   +12 more
doaj   +1 more source

Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions

open access: yesPharmaceutical Research, 2020
To provide whole-body physiologically based pharmacokinetic (PBPK) models of the potent clinical organic anion transporter (OAT) inhibitor probenecid and the clinical OAT victim drug furosemide for their application in transporter-based drug-drug ...
Hannah Britz   +8 more
semanticscholar   +1 more source

Effect of Probenecid on Pharmacokinetics and Tolerability of Olmesartan in Healthy Chinese Volunteers

open access: yesCurrent Therapeutic Research, 2014
Background: Olmesartan is an angiotensin II receptor antagonist and is effective and well tolerated in the treatment of arterial hypertension. Probenecid is a well-established hypouricemic agent for the treatment of hyperuricemia and gout. Objective: The
Kun-Yan Li, PhD   +6 more
doaj   +1 more source

Probenecid slows disease progression in a murine model of autosomal dominant polycystic kidney disease

open access: yesPhysiological Reports, 2023
Development of autosomal dominant polycystic kidney disease (ADPKD) involves renal epithelial cell abnormalities. Cystic fluid contains a high level of ATP that, among other effects, leads to a reduced reabsorption of electrolytes in cyst‐lining cells ...
Sergey N. Arkhipov   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy